References

What have we learned about how to prevent and treat antibody-mediated rejection in kidney transplantation?

10.1111/ajt.15859 · 2020 · External reference

Subclinical and borderline rejection are associated with death-censored graft loss after kidney transplantation: a systematic review and meta-analysis

10.1111/ctr.70536 · 2026 · External reference

The impact of donor-specific anti-HLA antibodies on late kidney allograft failure

10.1038/nrneph.2012.81 · 2012 · External reference

The Spectrum of renal allograft failure

10.1371/journal.pone.0162278 · 2016 · External reference

An updated banff schema for diagnosis of antibody-mediated rejection in renal allografts

10.1097/mot.0000000000000072 · External reference

Antibody-Mediated rejection of solid-organ allografts

10.1056/nejmra1802677 · 2018 · External reference

Biomarkers of rejection in kidney transplantation

10.1053/j.ajkd.2024.07.018 · 2025 · External reference

Molecular diagnosis of ABMR with or without donor-specific antibody in kidney transplant biopsies: differences in timing and intensity but similar mechanisms and outcomes

10.1111/ajt.17092 · 2022 · External reference

Antibody-mediated rejection, T cell-mediated rejection, and the injury-repair response: new insights from the genome Canada studies of kidney transplant biopsies

10.1038/ki.2013.300 · 2013 · External reference

Clinical role of the renal transplant biopsy

10.1038/nrneph.2011.213 · 2012 · External reference

To biopsy or not to biopsy: investigation of deteriorating kidney transplant function

10.1093/ndt/gfab041 · 2022 · External reference

Microvascular inflammation of the renal allograft: a reappraisal of the underlying mechanisms

10.3389/fimmu.2022.864730 · 2022 · External reference

Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure

10.1111/j.1600-6143.2009.02799.x · 2009 · External reference

The banff 2019 kidney meeting report (I): updates on and clarification of criteria for T cell- and antibody-mediated rejection

10.1111/ajt.15898 · 2020 · External reference

Beneficial effects of treatment of early subclinical rejection: a randomized study

10.1681/asn.v9112129 · 1998 · External reference

Natural history, risk factors, and impact of subclinical rejection in kidney transplantation

10.1097/01.tp.0000128167.60172.cc · 2004 · External reference

Predicting subsequent decline in kidney allograft function from early surveillance biopsies

10.1111/j.1600-6143.2005.01050.x · 2005 · External reference

Rejection of the kidney allograft

10.1056/nejmra0902927 · 2010 · External reference

Banff 2013 meeting report: inclusion of C4d-negative antibody-mediated rejection and antibody-associated arterial lesions

10.1111/ajt.12590 · 2014 · External reference

Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant

10.1111/j.1600-6143.2012.04013.x · 2012 · External reference

Non-HLA antibodies in transplantation

10.1097/mot.0000000000000348 · 2016 · External reference

Role of non-HLA antibodies in organ transplantation

10.1097/mot.0b013e328355f12b · 2012 · External reference

Determination and validation of an optimized scoring system for allograft outcomes in antibody-mediated rejection

2017 · External reference

Effect of human leukocyte antigen compatibility on kidney graft survival: comparative analysis of two decades

10.1097/01.tp.0000269725.74189.b9 · 2007 · External reference

BK Polyomavirus in solid organ transplantation

10.1111/ajt.12110 · 2013 · External reference

Cardiovascular disease after renal transplantation

10.1681/asn.v71158 · 1996 · External reference

Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era

10.1111/j.1600-6143.2004.00332.x · 2004 · External reference

An initial report from the French SOT COVID registry suggests high mortality due to COVID-19 in recipients of kidney transplants

10.1016/j.kint.2020.08.005 · 2020 · External reference

COVID-19 and kidney transplantation: results from the TANGO international transplant consortium

10.1111/ajt.16185 · 2020 · External reference

Safety and adequacy of renal transplant protocol biopsies

10.1111/j.1600-6143.2005.00988.x · 2005 · External reference

Real time central assessment of kidney transplant indication biopsies by microarrays: the INTERCOMEX study

10.1111/ajt.14329 · 2017 · External reference

Cell-free DNA and active rejection in kidney allografts

10.1681/asn.2016091034 · 2017 · External reference